Dasatinib
- Product NDC
- 0480-5103
- 11-digit product format
- 004805103
- Labeler code
- 0480
- Product ID
- 0480-5103_4f8ca317-4225-4d8f-b028-836e1dd07fe1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dasatinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals, Inc.
- Application
- ANDA211094
- Marketing category
- ANDA
- Marketing start
- 2025-09-18
- Substance
- DASATINIB
- Active strength
- 70 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dasatinib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DASATINIB | 70 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | RBZ1571X5H |
| Rxcui | 643105, 643107, 643109, 799047, 1045402, 1045406 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0480-5103-06 | Dasatinib | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0480-5103-06 | 00480510306 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-5103-06) | 2025-09-18 | No | No | Current |